Anemia, a prevalent condition characterized by a decrease in the number of red blood cells or less than the normal quantity of hemoglobin in the blood, presents a diagnostic challenge due to its multifactorial etiology. This article aims to provide a comprehensive diagnostic approach to anemia in clinical practice.
The initial evaluation of anemia should include a thorough patient history and physical examination. The history should focus on potential causes such as dietary habits, family history, and symptoms like fatigue, pallor, or dyspnea. The physical examination should assess for signs of systemic diseases which could contribute to anemia.
Basic laboratory investigations should include a complete blood count (CBC) with peripheral smear, reticulocyte count, and serum ferritin. More specific tests such as Vitamin B12, folate levels, or hemoglobin electrophoresis may be indicated based on initial findings. An elevated red cell distribution width (RDW) can indicate a mixed cause of anemia or an early stage of a developing anemia.
Further diagnostic refinement should be guided by the initial investigations. Microcytic anemia may indicate iron deficiency, thalassemia, or anemia of chronic disease. Normocytic anemia could be due to renal disease, malignancy, or aplastic anemia. Macrocytic anemia might suggest Vitamin B12 or folate deficiency, myelodysplastic syndrome, or alcoholism. Bone marrow examination may be necessary in cases of unexplained anemia.
Anemia is a complex disorder with a broad differential diagnosis. A systematic approach that includes a thorough history, physical examination, and appropriate laboratory investigations can help clinicians navigate this complexity. Ongoing research into the pathophysiology of anemia continues to inform and refine our diagnostic approach, promising more precise and personalized care for patients with this common condition.
1.
The Clues Hidden in Failed Prostate Cancer Trials
2.
Updates from the 2022 WHO classification of kidney epithelial tumors
3.
Immunotherapy and targeted radiation shrink liver tumors, enabling surgery
4.
We Don't Always Know What's 'Best' for Our Patients
5.
Conditional EU Nod for Weekly Pill in Pediatric Glioma
1.
AI on the Front Lines: Revolutionizing Breast Cancer Detection with Artificial Intelligence
2.
Gynecologic Oncology: Advances, Education, and Clinical Excellence
3.
Integrating Immunotherapy and Staging Guidelines in Lung Cancer Treatment
4.
Contemporary Frameworks in Oncology Across Clinical Settings
5.
Unlocking the Immune Arsenal: A Revolution in Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II
2.
Oropharyngeal Cancer in Relation to HPV Status
3.
Navigating the Complexities of Ph Negative ALL - Part XV
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
5.
Efficient Management of First line ALK-rearranged NSCLC - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation